MyD88 deficiency results in both cognitive and motor impairments in mice

Brain, Behavior, and Immunity

Volumn 26, Issue 6, 2012, Pages 880-885

  Drouin Ouellet, J ^a   LeBel, M ^a   Filali, M ^a,b   Cicchetti, F ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cognition; Innate immune system; Motor behaviors; MyD88

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALANCE IMPAIRMENT; COGNITIVE DEFECT; CONTROLLED STUDY; COORDINATION DISORDER; MAZE TEST; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; ROTAROD TEST; SPATIAL MEMORY; WORKING MEMORY;

ANIMALS; AVOIDANCE LEARNING; COGNITION DISORDERS; HOT TEMPERATURE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MOVEMENT DISORDERS; MYELOID DIFFERENTIATION FACTOR 88; PAIN MEASUREMENT; POSTURAL BALANCE; REACTION TIME;

EID: 84863868058     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.02.007     Document Type: Article

References (44)

1. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150.
2. Aguilar-Valles A., Flores C., Luheshi G.N. Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia. PLoS One 2010, 5:e10967.
3. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
4. Calich V.L., Pina A., Felonato M., Bernardino S., Costa T.A., Loures F.V. Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis. FEMS Immunol. Med. Microbiol. 2008, 53:1-7.
5. Cameron J.S., Alexopoulou L., Sloane J.A., DiBernardo A.B., Ma Y., Kosaras B., Flavell R., Strittmatter S.M., Volpe J., Sidman R., Vartanian T. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 2007, 27:13033-13041.
6. Cote M., Drouin-Ouellet J., Cicchetti F., Soulet D. The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity. Brain Behav. Immun. 2011, 6:1143-1152.
7. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., Rawlins J.N., Perry V.H. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 2009, 65:304-312.
8. Deacon R.M. Housing, husbandry and handling of rodents for behavioral experiments. Nat. Protoc. 2006, 1:936-946.
9. Drouin-Ouellet J., Gibrat C., Bousquet M., Calon F., Kriz J., Cicchetti F. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration. J Neuroinflamm. 2011, 8:137.
10. Egan C.E., Sukhumavasi W., Butcher B.A., Denkers E.Y. Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii. Clin. Exp. Immunol. 2009, 156:17-24.
11. Fernagut P.O., Chalon S., Diguet E., Guilloteau D., Tison F., Jaber M. Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice. Neuroscience 2003, 116:1123-1130.
12. Filali M., Dequen F., Lalonde R., Julien J.P. Sensorimotor and cognitive function of a NEFL(P22S) mutant model of Charcot-Marie-Tooth disease type 2E. Behav. Brain Res. 2010, 219:175-180.
13. Filali M., Lalonde R. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease. Brain Res. 2009, 1292:93-99.
14. Filali M., Lalonde R., Rivest S. Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease. Physiol. Behav. 2011, 104:880-885.
15. Gilmore J.H., Fredrik Jarskog L., Vadlamudi S., Lauder J.M. Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 2004, 29:1221-1229.
16. Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science 1994, 265:1826-1831.
17. Hao W., Liu Y., Liu S., Walter S., Grimm M.O., Kiliaan A.J., Penke B., Hartmann T., Rube C.E., Menger M.D., Fassbender K. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. Brain 2011, 134:278-292.
18. Holmes A., Yang R.J., Lesch K.P., Crawley J.N., Murphy D.L. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 2003, 28:2077-2088.
19. Jones B.J., Roberts D.J. The quantiative measurement of motor inco-ordination in naive mice using an accelerating rotarod. J. Pharm. Pharmacol. 1968, 20:302-304.
20. Kang J., Rivest S. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J. Cell Biol. 2007, 179:1219-1230.
21. Kim Y., Zhou P., Qian L., Chuang J.Z., Lee J., Li C., Iadecola C., Nathan C., Ding A. MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J. Exp. Med. 2007, 204:2063-2074.
22. Lim J.E., Kou J., Song M., Pattanayak A., Jin J., Lalonde R., Fukuchi K. MyD88 deficiency ameliorates beta-amyloidosis in an animal model of Alzheimer's disease. Am. J. Pathol. 2011, 179:1095-1103.
23. Lim J.E., Song M., Jin J., Kou J., Pattanayak A., Lalonde R., Fukuchi K. The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice. Behav. Brain Res. 2011, 227:36-42.
24. Lynch M.A. Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. Vitam. Horm. 2002, 64:185-219.
25. Matsuura K., Kabuto H., Makino H., Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J. Neurosci. Methods 1997, 73:45-48.
26. Mehler M.F., Kessler J.A. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci. 1997, 20:357-365.
27. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev. Neurosci. 1992, 14:1-10.
28. Meyer U., Feldon J. Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology 2009, 206:587-602.
29. Ogawa N., Hirose Y., Ohara S., Ono T., Watanabe Y. A simple quantitative bradykinesia test in MPTP-treated mice. Res. Commun. Chem. Pathol. Pharmacol. 1985, 50:435-441.
30. Okun E., Griffioen K., Barak B., Roberts N.J., Castro K., Pita M.A., Cheng A., Mughal M.R., Wan R., Ashery U., Mattson M.P. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:15625-15630.
31. Parish C.L., Finkelstein D.I., Tripanichkul W., Satoskar A.R., Drago J., Horne M.K. The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J. Neurosci. 2002, 22:8034-8041.
32. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 2008, 63:801-808.
33. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 2007, 9:1081-1088.
34. Ropert C., Franklin B.S., Gazzinelli R.T. Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria. Semin. Immunopathol. 2008, 30:41-51.
35. Sango K., Yamanaka S., Hoffmann A., Okuda Y., Grinberg A., Westphal H., McDonald M.P., Crawley J.N., Sandhoff K., Suzuki K., Proia R.L. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 1995, 11:170-176.
36. Sedelis M., Schwarting R.K., Huston J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav. Brain. Res. 2001, 125:109-125.
37. Shechter R., Ronen A., Rolls A., London A., Bakalash S., Young M.J., Schwartz M. Toll-like receptor 4 restricts retinal progenitor cell proliferation. J. Cell Biol. 2008, 183:393-400.
38. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129:3006-3019.
39. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004, 16:3-9.
40. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M.P. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 2007, 104:13798-13803.
41. Tang S.C., Lathia J.D., Selvaraj P.K., Jo D.G., Mughal M.R., Cheng A., Siler D.A., Markesbery W.R., Arumugam T.V., Mattson M.P. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 2008, 213:114-121.
42. Terrando N., Monaco C., Ma D., Foxwell B.M., Feldmann M., Maze M. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A 2010, 107:20518-20522.
43. Tjolsen A., Rosland J.H., Berge O.G., Hole K. The increasing-temperature hot-plate test: an improved test of nociception in mice and rats. J. Pharmacol. Methods 1991, 25:241-250.
44. Winter C., Djodari-Irani A., Sohr R., Morgenstern R., Feldon J., Juckel G., Meyer U. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int. J. Neuropsychopharmacol. 2009, 12:513-524.